Win Maung Hay Mar, Chan-On Waraporn, Kunkeaw Nawapol, Khaenam Prasong
Center for Standardization and Product Validation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
EXCLI J. 2020 Jan 20;19:154-166. doi: 10.17179/excli2019-1893. eCollection 2020.
The incidence of cholangiocarcinoma (CCA) has risen in many countries, but there is still no appropriate screening and treatment available. The growing number of microarray data published todays can be a powerful resource for the discovery of biomarkers to tackle challenges in the management of CCA. This study analyzed multiple microarray datasets to identify the common transcriptional networks in CCA and select a possible biomarker for functional study in CCA cell lines. A systematic searching identified 4 microarray datasets from Gene Expression Omnibus (GEO) repository and PubMed articles. Differential expression analysis between tumor and normal tissues was performed in each dataset. In order to characterize the common expression pattern, differentially expressed genes (DEGs) from all datasets were combined and visualized by hierarchical clustering and heatmap. Gene enrichment analysis performed in each cluster revealed that over-expressed DEGs were enriched in cell cycle, cell migration and response to cytokines while under-expressed DEGs were enriched in metabolic processes such as oxidation-reduction, lipid, and drug. To explain tumor characteristics, genes enriched in cell migration and response to cytokines were further investigated. Among these genes, CCL20 was selected for functional study because its role has never been studied in CCA. Moreover, its signaling may be regulated by disrupting its only receptor, CCR6. Treatment with recombinant CCL20 induced higher cell migration and increased expression of N-cad. In contrast, knockdown of CCR6 by siRNA reduced cell migration ability and decreased N-cadherin level. Altogether, these results suggested the contribution of CCL20/CCR6 signaling in cell migration through epithelial-mesenchymal transition process. Thus, CCL20/CCR6 signaling might be a target for the management of CCA.
胆管癌(CCA)的发病率在许多国家呈上升趋势,但仍缺乏合适的筛查和治疗方法。如今,越来越多发表的微阵列数据可成为发现生物标志物的强大资源,以应对CCA管理中的挑战。本研究分析了多个微阵列数据集,以识别CCA中的常见转录网络,并选择一种可能的生物标志物用于CCA细胞系的功能研究。通过系统检索,从基因表达综合数据库(GEO)存储库和PubMed文章中确定了4个微阵列数据集。在每个数据集中对肿瘤组织和正常组织进行差异表达分析。为了表征共同的表达模式,将所有数据集的差异表达基因(DEG)合并,并通过层次聚类和热图进行可视化。对每个聚类进行的基因富集分析表明,过表达的DEG富集在细胞周期、细胞迁移和细胞因子反应中,而低表达的DEG富集在氧化还原、脂质和药物等代谢过程中。为了解释肿瘤特征,对富集在细胞迁移和细胞因子反应中的基因进行了进一步研究。在这些基因中,选择CCL20进行功能研究,因为其在CCA中的作用从未被研究过。此外,其信号传导可能通过破坏其唯一受体CCR6来调节。用重组CCL20处理可诱导更高的细胞迁移并增加N-cad的表达。相反,用小干扰RNA(siRNA)敲低CCR6可降低细胞迁移能力并降低N-钙黏蛋白水平。总之,这些结果表明CCL20/CCR6信号传导在通过上皮-间质转化过程的细胞迁移中起作用。因此,CCL20/CCR6信号传导可能是CCA管理的一个靶点。